Notice to Clarify Placement of “Certification of Eligibility” in Applications Submitted for NIDA's PAR-11-060 "Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)"

Notice Number: NOT-DA-13-013

Key Dates
Release Date: January 17, 2013  

Related Announcements
PAR-11-060

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

This Notice issued by the National Institute on Drug Abuse is to clarify the placement of the "Certification of Eligibility" in applications submitted for PAR-11-060 "Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)".

PAR-11-060 instructs applicants to place the “Certification of Eligibility” as page #1 then the “Face Page” as page #2.  Applicants are now being advised to place the Face Page as page #1 and “Certification of Eligibility” as page #2.

Section IV.6. Other Submission Requirements of the FOA should be revised to state:

Organization

Applications should be organized as follows.

SECTION I

Face Page

Certification of Eligibility

Description, Project/Performance Sites, Senior/Key Personnel, Other Significant Contributors, and Human Embryonic Stem Cells

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Pamela Goodlow
Special Populations Office
National Institute on Drug Abuse
Telephone: 301-443-0441
Email: pgoodlow@nida.nih.gov

NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.